The ISCT Committee on the Ethics of Cell and Gene Therapy (ECGT) strives to:
Identify key aspects of unproven cellular interventions in order to promote and share effective strategies between scientific/medical societies, health-care stakeholders, patient associations, and individuals, promoting the role of rigorous research and appropriate investigation and application of cell based therapies.
Learn more about Committee Resources - Click here to view
Formerly known as the ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell and Gene Therapies (PTF).
Miguel Forte, MD, PhDVice - Chair, Industry (June 2019-2022) AdBioBrusselsBelgium
Hind Al Belushi, PhDThe Royal HospitalMuscatSultanate of Oman
Beth E. Roxland, JD, MBioethics
Roxland Consultants Ltd.New York, NYUnited States
Alok Srivastava, MBBS, MD, FRACP, FRCPA, FRCPChristian Medical CollegeVelloreIndia
The ISCT ECGT Committee website contains numerous resources that strive to characterize unproven and unethical cell and gene interventions, and promote safe and effective practices worldwide.
View All Committees